$Anixa Biosciences (ANIX.US)$ Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio Monday, 14th April at 8:00 am SAN JOSE, Calif., April 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has received a Notice of Allowance from the United...
$Anixa Biosciences (ANIX.US)$Benzinga· 5 mins ago EXCLUSIVE: Anixa Biosciences Tells Benzinga Co. Receives Notice Of Allowance From US Patent And Trademark Office For Patent Covering Breast Cancer Vaccine Technology
$Anixa Biosciences (ANIX.US)$On Monday, the United States Patent and Trademark Office (USPTO) issued a Notice of Allowance for a key patent application covering Anixa Biosciences, Inc.'s (NASDAQ:ANIX) ovarian cancer vaccine technology. The patent includes broad claims related to methods of eliciting an immune response targeting the Anti-Mullerian Hormone Receptor, Type II (AMHR2), a target for ovarian cancer prevention and treatment. Anixa's ovarian cancer vaccine is being developed in colla...
$Anixa Biosciences (ANIX.US)$ Anixa Biosciences Tells Benzinga Co. Receives Notice Of Allowance From USPTO For ovarian Cancer Vaccine EXCLUSIVE: Anixa Biosciences Tells Benzinga 'The Patent Includes Broad Claims Related to Methods of Eliciting an Immune Response Targeting Anti-Mullerian Hormone Receptor, Type II (AMHR2)'
$Anixa Biosciences (ANIX.US)$ Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial Wednesday, 26th February at 8:00 am SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its no...
NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
Huaw
:
I do not understand why HMR only had a total of 28.37 million shares yesterday. Today, it has become a total of 56.75 million shares. It's almost doubled, and the Market Cap has also doubled. Why is this happening?
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Anixa Biosciences Stock Discussion
Cancer Treatment Innovator Anixa Biosciences Takes Center Stage at Elite Nasdaq Conference
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Monday, 14th April at 8:00 am
SAN JOSE, Calif., April 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has received a Notice of Allowance from the United...
EXCLUSIVE: Anixa Biosciences Tells Benzinga Co. Receives Notice Of Allowance From US Patent And Trademark Office For Patent Covering Breast Cancer Vaccine Technology
The patent includes broad claims related to methods of eliciting an immune response targeting the Anti-Mullerian Hormone Receptor, Type II (AMHR2), a target for ovarian cancer prevention and treatment.
Anixa's ovarian cancer vaccine is being developed in colla...
Anixa Biosciences Tells Benzinga Co.
Receives Notice Of Allowance From
USPTO For ovarian Cancer Vaccine
EXCLUSIVE: Anixa Biosciences Tells Benzinga 'The Patent Includes Broad Claims Related to Methods of Eliciting an Immune Response Targeting Anti-Mullerian Hormone Receptor, Type II (AMHR2)'
Can Anixa's Ovarian Cancer CAR-T Therapy Advance After Successful 10-Fold Dose Escalation?
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Wednesday, 26th February at 8:00 am
SAN JOSE, Calif., Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its no...
Can This Breast Cancer Vaccine Change Prevention Forever? Anixa's Trial Shows 70% Response Rate
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (pres...
Can This Groundbreaking CAR-T Therapy Transform Ovarian Cancer Treatment?
No comment yet